UNSPSC 51332905: Metergoline

This classification denotes a chemotherapy regimen in current use with the molecular formula C25H29N3O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 1501393LY5, chemically known as 1,6-dimethyl-8-beta-carbobenzyloxaminomethyl-10-alpha-ergoline but more generally known as metergoline, which bears U.S. NIH Compound Identifier 28693. European Medicines Agency schedules Metergoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08824MIG.

UNSPSC 51332905 Metergoline is a Commodity code that covers pharmaceutical products and related health supplies procured by state and local health authorities. Recent opportunities show state and local governments buying naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing arrangements. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). These procurements support community health initiatives, state pharmacy benefit programs, and regional pharmaceutical distribution networks serving multiple jurisdictions.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, requesting information from manufacturers and distributors on direct contracting models outside traditional pharmacy benefit manager and wholesaler channels. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026; the contract requires vendors to work through three authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson) and mandates compliance with cGMP, Drug Supply Chain Security Act standards, and FDA requirements, with evaluation weighted 75 percent on price competitiveness and 25 percent on administrative and operational compliance factors.